Tag: ISC 2024
Stroke transfer protocols: what does the road ahead look like?
A number of somewhat conflicting studies have been published over the past year regarding triage and transport protocols for stroke. In light of the...
Transradial achieves non-inferiority but procedural delays may mean femoral access remains...
In stroke patients undergoing a mechanical thrombectomy procedure, access via the radial artery may be non-inferior to access through the femoral artery in terms...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA) hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
One-year TESLA and SELECT2 data favour thrombectomy in large-core stroke patients
One-year follow-up data from two randomised controlled trials (RCTs) evaluating mechanical thrombectomy in patients with ischaemic strokes caused by large-core infarct volumes have demonstrated...
Brain stimulation plus rehabilitation produces improved upper-limb function in stroke survivors
Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands, and maintain these improvements for one year, within a...
Reteplase demonstrates superiority to alteplase in acute ischaemic stroke trial
Reteplase has demonstrated potential as an alternative to alteplase in patients requiring intravenous thrombolysis (IVT) to treat acute ischaemic stroke, as per the findings...
SNIS acknowledges “major shift” in chronic SDH treatment following new trial...
In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic...
Addition of MMA embolisation reduces haematoma recurrence or progression in MAGIC-MT...
The use of middle meningeal artery (MMA) embolisation alongside standard care has been deemed superior to standard care alone for patients with symptomatic, non-acute...
Dual-stent retriever strategy demonstrates promise in TWIN2WIN clinical trial
Late-breaking findings from the TWIN2WIN trial—presented recently at the International Stroke Conference (ISC; 7–9 February, Phoenix, USA)—have demonstrated the potential benefits of performing mechanical...
Viz.ai gains US FDA 510(k) clearance for intracerebral haemorrhage imaging algorithm
Viz.ai has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Viz Intracerebral Haemorrhage (ICH) Plus algorithm, which is intended...
RapidAI highlights TIMELESS trial publication among other key ISC 2024 presentations
RapidAI has announced the publication of TIMELESS—a randomised trial evaluating the use of tenecteplase in acute ischaemic stroke treatment—in the New England Journal of Medicine...
STEM study finds improved outcomes with MMA embolisation over standard care...
Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared...
ZODIAC trial reveals clinical benefits of zero-degree head positioning prior to...
Laying large vessel occlusion (LVO) ischaemic stroke patients flat with their heads at a zero-degree angle prior to a mechanical thrombectomy procedure has resulted...
Mivi Neuroscience presents primary endpoint results from EvaQ trial
Mivi Neuroscience has announced the primary endpoint results of its EvaQ trial—a prospective, multicentre, global, single-arm, US Food and Drug Administration (FDA)-regulated investigational device...
MMA embolisation plus surgery reduces risk of subdural haematoma recurrence in...
Middle meningeal artery (MMA) embolisation—the injection of a liquid embolic substance to block an artery feeding the brain’s dura—along with surgery for subacute or...
AI-based decision support system helps improve post-stroke vascular outcomes at three...
Ischaemic stroke survivors who received care recommendations from an artificial intelligence (AI)-based system experienced fewer recurrent strokes and heart attacks, and a lower rate...
Halted MOST trial finds no benefit when adding blood thinners to...
Giving blood thinners in addition to clot-busting medications does not improve ischaemic stroke patients’ outcomes at 90 days, according to findings from the MOST trial, which...
